Soleno’s stock drops despite rise in Prader-Willi drug salesnews2025-11-05T14:40:13+00:00November 5th, 2025|Endpoints News|
Centessa says early data for narcolepsy drug support registrational plansnews2025-11-05T12:00:41+00:00November 5th, 2025|Endpoints News|
Research institute FutureHouse debuts AI scientist Kosmos and for-profit spinoffnews2025-11-05T12:00:33+00:00November 5th, 2025|Endpoints News|
Cardio biotech Braveheart gets $185M, names Biogen CEO as its chairnews2025-11-05T11:00:13+00:00November 5th, 2025|Endpoints News|
Novo Nordisk sales miss underlines its need for Metseranews2025-11-05T10:24:34+00:00November 5th, 2025|Endpoints News|
‘Everybody’s talking about it’: Metsera bidding war grips the obesity fieldnews2025-11-05T10:00:02+00:00November 5th, 2025|Endpoints News|
Arena BioWorks shuts down after investors pull plug on bid to reinvent biotechnews2025-11-04T23:25:15+00:00November 4th, 2025|Endpoints News|
Madrigal CEO welcomes MASH competition from Novo as demand climbs higher for Rezdiffranews2025-11-04T20:25:52+00:00November 4th, 2025|Endpoints News|
What health tech stands to gain as pharma goes DTCnews2025-11-04T16:50:05+00:00November 4th, 2025|Endpoints News|
Incyte, Prelude ink rare blood cancer pact; Merck takes back rights to Prometheus assetnews2025-11-04T15:31:15+00:00November 4th, 2025|Endpoints News|
